Standard of Care: Managing Magnesium Daily
At a Glance
Children with familial hypomagnesemia with secondary hypocalcemia usually need lifelong, individualized magnesium replacement. IV magnesium and sometimes calcium treat emergencies, while split oral doses, blood tests, and symptom monitoring support safe daily care.
Treatment for Familial hypomagnesemia with secondary hypocalcemia (HSH) is a lifelong process that evolves from an emergency rescue to a long-term balancing act. Because your child’s body cannot naturally absorb magnesium through the gut properly, the goal of treatment is to safely supplement enough magnesium into the bloodstream to keep the brain, heart, and muscles working correctly [1][2].
Important: This guide does not replace your treating specialist’s plan. Do not increase, decrease, switch salts, or stop treatments based on this section.
Acute Management: The Emergency Rescue
When a child is first diagnosed, they are often in the middle of a medical crisis, such as a seizure. In these moments, oral medication is not enough because it takes too long to absorb and the “gut channel” (TRPM6) is impaired [3].
- Intravenous (IV) Magnesium: Doctors in the hospital will administer magnesium directly into the vein to bypass the digestive system entirely. This provides rapid stability to the brain and heart under cardiac monitoring [1][4].
- Intravenous (IV) Calcium: Because magnesium depletion causes the parathyroid glands to “shut down,” most children also have dangerously low calcium levels. IV calcium is given alongside magnesium in the hospital depending on the severity and symptoms of hypocalcemia [3][1].
- The Turning Point: Once magnesium levels begin to rise, the body’s natural calcium-regulating system often “wakes up.” Many children find that their calcium levels eventually return to normal once their magnesium is stabilized, but tapering or stopping calcium is strictly a hospital and medical decision based on labs [1][2]. Families should not stop calcium or self-treat a crisis.
Chronic Management: High-Dose Oral Therapy
After the initial crisis is over, treatment shifts to daily oral magnesium supplementation. Because the body only absorbs a small fraction of what is taken by mouth in HSH, the doses required are often much higher than standard pediatric vitamins [2][5].
Choosing a Formulation
There is no single “best” magnesium for every child, but different salts contain very different amounts of elemental magnesium. Common options include:
If one type causes too much distress, your doctor may switch to another or use a “slow-release” version to improve tolerance [1][9]. Never switch between different salts or brands, and never crush modified-release products on your own. You must ensure dosing is understood in terms of elemental magnesium and directed by the treating clinician.
Managing Side Effects
The most common challenge with HSH treatment is osmotic diarrhea. Magnesium naturally pulls water into the intestines, which can cause loose stools, especially at the high doses needed for HSH [1][10].
- Dose Splitting: Instead of one large dose, doctors often recommend splitting the daily amount into three, four, or more small doses spread throughout the day [8].
- Individualization: Treatment must be a “custom fit.” Your care team will work to find the highest dose your child can tolerate without severe diarrhea, while still keeping their symptoms under control [1].
Defining a Successful Response
In HSH, “success” is not defined by a perfect blood test result. In fact, many children with HSH will always have borderline low magnesium levels on their lab reports despite rigorous treatment [1][7].
Instead, doctors focus on clinical stability:
- Symptom Control: The primary goal is that the child is seizure-free and does not experience tremors or muscle spasms [1][11]. However, seizure freedom does not prove that the magnesium level is safe.
- Normal Calcium: If magnesium levels are “high enough,” the parathyroid glands will function properly, and blood calcium will stay in the normal range [1][12].
- Normal Growth and Development: Children who are consistently treated usually have a good long-term outlook and reach their developmental milestones [13][2].
The Risk of Over-Treatment
While rare with HSH, it is possible to give too much magnesium, especially if a child’s kidney function changes (for example, due to dehydration from a stomach bug) [14][6]. Signs of too much magnesium (hypermagnesemia) or dangerous hypomagnesemia include severe sleepiness, very weak muscles (floppiness), breathing difficulty, fainting, or a very slow heart rate [14][6]. If you notice these symptoms, prompt emergency assessment is required. Regular blood monitoring is the best way to ensure your child stays in the “safe zone” [15][14].
Common questions in this guide
Why might a child with HSH need IV magnesium during an emergency?
Why is calcium sometimes given along with magnesium?
What should I know about my child’s daily magnesium medicine?
How can magnesium-related diarrhea be managed?
What does successful HSH treatment look like if magnesium is still low on the lab report?
What are warning signs that magnesium levels may be unsafe?
Get notified when new evidence is published on Primary hypomagnesemia with secondary hypocalcemia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (15)
- 1
Treatment Difficulties in Hypomagnesemia Secondary to the Transient Receptor Potential Melastatin 6 Gene: A Case Report with Novel Mutation
Yücel H, Genç Sel Ç, Kasapkara ÇS, et al.
Journal of clinical research in pediatric endocrinology 2021; (13(1)):114-118 doi:10.4274/jcrpe.galenos.2020.2020.0004.
PMID: 32302086 - 2
A novel TRPM6 variant (c.3179T>A) causing familial hypomagnesemia with secondary hypocalcemia.
Lomelino-Pinheiro S, Margarida B, Lages AS
Endocrinology, diabetes & metabolism case reports 2020; (2020()).
PMID: 32369769 - 3
A Rare Case of Neonatal Hypomagnesemia with Secondary Hypocalcemia Caused by a Novel Homozygous TRPM6 Gene Variant.
Uddin MS, Alradhi AY, Alqathani FMN, et al.
The American journal of case reports 2024; (25()):e942498 doi:10.12659/AJCR.942498.
PMID: 38528672 - 4
Familial hypomagnesemia with secondary hypocalcemia: a novel TRPM6 mutation associated with treatment-resistant migraine in a North African family.
Paola PM, Gianni C, Emanuele M, et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026; (47(10)).
PMID: 42830330 - 5
Hypomagnesemia and functional hypoparathyroidism due to novel mutations in the Mg-channel TRPM6.
Astor MC, Løvås K, Wolff AS, et al.
Endocrine connections 2015; (4(4)):215-22 doi:10.1530/EC-15-0066.
PMID: 26273099 - 6
Hypermagnesemia in a 20-month-old healthy girl caused by the use of a laxative: a case report.
Araki K, Kawashima Y, Magota M, Shishida N
Journal of medical case reports 2021; (15(1)):129 doi:10.1186/s13256-021-02686-9.
PMID: 33750439 - 7
[A case report of primary hypomagnesemia with secondary hypocalcemia caused by TRPM6 gene variants].
Zhou MY, Tang XJ, Lin SX, Chen CF
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2026; (28(1)):107-110 doi:10.7499/j.issn.1008-8830.2507066.
PMID: 41582756 - 8
Hypomagnesemia with Secondary Hypocalcemia (HSH): a Case Report.
Zhao C, Lin Y, Jiang Z
Clinical laboratory 2023; (69(10)) doi:10.7754/Clin.Lab.2023.230505.
PMID: 37844054 - 9
An Advanced Formulation of a Magnesium Dietary Supplement Adapted for a Long-Term Use Supplementation Improves Magnesium Bioavailability: In Vitro and Clinical Comparative Studies.
Dualé C, Cardot JM, Joanny F, et al.
Biological trace element research 2018; (186(1)):1-8 doi:10.1007/s12011-018-1277-2.
PMID: 29524192 - 10
Intestinal hypomagnesemia in an Iranian patient with a novel TRPM6 variant: a case report and review of the literature.
Kamali F, Jamee M, Sayer JA, et al.
CEN case reports 2023; (12(4)):413-418 doi:10.1007/s13730-023-00785-8.
PMID: 36967423 - 11
Three cases of hereditary hypomagnesemia with secondary hypocalcemia caused by novel TRPM6 gene mutations and a literature review.
Yang M, Zheng Z, Shan X, Luo Y
Journal of pediatric endocrinology & metabolism : JPEM 2026; (39(9)):917-925 doi:10.1515/jpem-2026-0185.
PMID: 42324811 - 12
Clinical Spectrum of Primary Hypomagnesemia with Secondary Hypocalcemia due to TRPM6 Mutation.
Aftab S, Anjum MN, Aslam N, et al.
Hormone research in paediatrics 2026; (99(7)):1045-1050 doi:10.1159/000547303.
PMID: 40853861 - 13
Long-term Clinical Follow-up of Patients with Familial Hypomagnesemia with Secondary Hypocalcemia
Bayramoğlu E, Keskin M, Aycan Z, et al.
Journal of clinical research in pediatric endocrinology 2021; (13(3)):300-307 doi:10.4274/jcrpe.galenos.2021.2020.0192.
PMID: 33565749 - 14
Postoperative respiratory depression caused by iatrogenic hypermagnesaemia.
Premkumar CR, Parthasarathy R, Kumar S, Vijaykumar S
Anaesthesia reports 2022; (10(1)):e12154 doi:10.1002/anr3.12154.
PMID: 35360363 - 15
Hypocalcemia and hyperkalemia during magnesium infusion therapy in a pre-eclamptic patient.
Hudali T, Takkar C
Clinical case reports 2015; (3(10)):827-31 doi:10.1002/ccr3.356.
PMID: 26509017
This page explains general magnesium and calcium management for children with HSH for informational purposes only and does not replace the child’s treating specialist’s medical advice. Do not change doses, switch products, or stop treatment without guidance from the care team.